Dr. Al-Atrash is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
Cleveland Clinic FoundationResidency, Internal Medicine, 2002 - 2005
Texas College of Osteopathic MedicineClass of 2002
Certifications & Licensure
FL State License 2021 - Present
AZ State License 2023 - 2026
TX State License 2005 - 2026
AL State License 2023 - 2025
GA State License 2023 - 2025
LA State License 2023 - 2025
MS State License 2023 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Nivolumab and Ipilimumab After Donor Stem Cell Transplant in Treating Patients With High Risk Refractory or Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Start of enrollment: 2018 Oct 11
- 2018-0674 - IL-7 for T-Cell Recovery Post Haplo and CB Transplant - Phase I/II Start of enrollment: 2020 Sep 29
Publications & Presentations
PubMed
- Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer.Vladimir Roudko, Diane Marie Del Valle, Emir Radkevich, Geoffrey Kelly, Xie Hui
Journal for Immunotherapy of Cancer. 2025-02-25 - Restrictive Ventilatory Defects Following Hematopoietic Stem Cell Transplant Are Associated With Increased Mortality.Mansour Alkhunaizi, Felipe Soto-Lanza, Cheuk Hong Leung, Neel Bhan, Lara Bashoura
Transplantation and Cellular Therapy. 2025-02-05 - 1 citationsEfficacy and Safety of Gilteritinib versus Sorafenib as Post-Transplant Maintenance in Patients With FLT3-ITD Acute Myeloid Leukemia.Jason Yeh, Oren Pasvolsky, Rima M Saliba, Bradley Figgins, Christopher Wang
Clinical Lymphoma, Myeloma & Leukemia. 2024-11-01
Grant Support
- MD Anderson Cancer Immune Monitoring and Analysis Center MDA-CIMACUNIVERSITY OF TX MD ANDERSON CAN CTR2017–2028
- MD Anderson Cancer Immune Monitoring and Analysis Center MDA-CIMACUNIVERSITY OF TX MD ANDERSON CAN CTR2017–2028
- Enhancing CAR T Cell Homing Through GlycoengineeringUNIVERSITY OF TX MD ANDERSON CAN CTR2023–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
